Quick Answer
CUMBERLAND PHARMACEUTICALS INC reported Revenue From Contract With Customer Excluding Assessed Tax of $44.52 million for the year ending 2025.
- CUMBERLAND PHARMACEUTICALS INC showed an increase of +17.6% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from CUMBERLAND PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on March 9, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 4 years of available data (2022 to 2025), CUMBERLAND PHARMACEUTICALS INC's Revenue From Contract With Customer Excluding Assessed Tax has grown by 6.0%.
- Historical annual values: Fiscal year 2025: $44.52 million | Fiscal year 2024: $37.87 million | Fiscal year 2023: $39.55 million | Fiscal year 2022: $42.01 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: